Literature DB >> 14614448

DeltaNp73 can modulate the expression of various genes in a p53-independent fashion.

Natalia N Kartasheva1, Claudia Lenz-Bauer, Oliver Hartmann, Helmut Schäfer, Martin Eilers, Matthias Dobbelstein.   

Abstract

DeltaNp73alpha is an isoform of the p53 homologue p73 that lacks an amino-terminal transactivation domain and antagonizes the induction of gene expression by p53. Here, we examined whether DeltaNp73alpha might also modulate cellular transcription in the absence of p53. The expression of DeltaNp73alpha in the p53-/- cell line H1299 reduced the mRNA levels of p21/CDKN1A, but did not affect other p53-responsive genes. Correspondingly, the p21/CDKN1A promoter was downregulated by DeltaNp73alpha in reporter assays, whereas other p53-responsive promoters were not inhibited. To identify additional genes that respond to DeltaNp73alpha in the absence of p53, microarrays carrying 4600 cDNA clones were hybridized. The expression of 30 genes was found to be altered more than threefold by overexpressed DeltaNp73alpha. For instance, DeltaNp73alpha increased the expression of EGR1 and CDC6, whereas it decreased the mRNA levels of c-MYC, cyclin A2/CCNA2, NF-kappaB1, ODC1, and RET finger protein/RFP. Semiquantitative reverse transcription-PCR confirmed these results and further revealed that the influence of DeltaNp73alpha on the regulation of these genes differs from other p73 isoforms and p53. We conclude that the impact of DeltaNp73alpha on gene expression is not limited to p53-responsive genes. Rather, DeltaNp73alpha can regulate the expression of a variety of genes independently of p53.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614448     DOI: 10.1038/sj.onc.1207138

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Cancer Invest       Date:  2018-11-05       Impact factor: 2.176

Review 2.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

Review 3.  The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.

Authors:  V Baron; E D Adamson; A Calogero; G Ragona; D Mercola
Journal:  Cancer Gene Ther       Date:  2006-02       Impact factor: 5.987

Review 4.  The p53 circuit board.

Authors:  Kelly D Sullivan; Corrie L Gallant-Behm; Ryan E Henry; Jean-Luc Fraikin; Joaquín M Espinosa
Journal:  Biochim Biophys Acta       Date:  2012-02-07

5.  Induction of the small heat shock protein alphaB-crystallin by genotoxic stress is mediated by p53 and p73.

Authors:  Joseph R Evans; Joshua D Bosman; Lauren Brown-Endres; Fruma Yehiely; Vincent L Cryns
Journal:  Breast Cancer Res Treat       Date:  2009-09-24       Impact factor: 4.872

6.  p73 plays a role in erythroid differentiation through GATA1 induction.

Authors:  Fernando Marqués-García; Nuria Ferrandiz; Rosalía Fernández-Alonso; Laura González-Cano; Marta Herreros-Villanueva; Manuel Rosa-Garrido; Belén Fernández-García; José P Vaque; Margarita M Marqués; María Eugenia Alonso; José Carlos Segovia; Javier León; María C Marín
Journal:  J Biol Chem       Date:  2009-06-09       Impact factor: 5.157

Review 7.  p73 as a pharmaceutical target for cancer therapy.

Authors:  Andrea Bisso; Licio Collavin; Giannino Del Sal
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

8.  ∆Np73 is capable of inducing apoptosis by co-ordinately activating several BH3-only proteins.

Authors:  Dámaso Sánchez-Carrera; Mikel García-Puga; Lucrecia Yáñez; Íñigo Romón; Carlos Pipaón
Journal:  Biosci Rep       Date:  2015-04-28       Impact factor: 3.840

9.  TAp73beta and DNp73beta activate the expression of the pro-survival caspase-2S.

Authors:  Wen Hong Toh; Emmanuelle Logette; Laurent Corcos; Kanaga Sabapathy
Journal:  Nucleic Acids Res       Date:  2008-07-08       Impact factor: 16.971

10.  TAp73β-mediated suppression of cell migration requires p57Kip2 control of actin cytoskeleton dynamics.

Authors:  Johanna Rodhe; Edel Kavanagh; Bertrand Joseph
Journal:  Oncotarget       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.